A study to evaluate the safety and efficacy profile of Formoterol/fluticasone-propionate in patients with asthma in real world setting

Trial Profile

A study to evaluate the safety and efficacy profile of Formoterol/fluticasone-propionate in patients with asthma in real world setting

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Sep 2017

At a glance

  • Drugs Formoterol/fluticasone propionate (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Acronyms AffIRM
  • Most Recent Events

    • 18 Sep 2017 New trial record
    • 12 Sep 2017 According to a Mundipharma media release, data from the study has been presented at the European Respiratory Society International Congress (ERS) 2017.
    • 12 Sep 2017 Results published in a Mundipharma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top